A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19 | NEJM
Original Article from The New England Journal of Medicine — A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19
Original Article from The New England Journal of Medicine — A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19
In heart failure, “the paradox is that at a time that we’re seeing these increases in mortality, we also have access to better medications,” Mount…
This cohort study evaluates recent reversals in declines in cardiovascular mortality and whether they vary across sociodemographic categories.
This cohort study evaluates recent reversals in declines in cardiovascular mortality and whether they vary across sociodemographic categories.
AbstractBackgroundMineralocorticoid receptor antagonists (MRAs) are underused in patients with kidney dysfunction, and their efficacy among patients with chronic kidney disease (CKD) is uncertain.O…
ESC Heart Failure is the open access journal of the ESC Heart Failure Association, dedicated to the advancement of knowledge in the field of heart…
ESC Heart Failure is the open access journal of the ESC Heart Failure Association, dedicated to the advancement of knowledge in the field of heart…
Correspondence to: Ambarish Pandey, MD, MSCS, Assistant Professor of Medicine, Division of Cardiology, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX…
This study performs a systematic review to identify which types of system-level initiatives are most effective at improving guideline-directed medical therapy use among patients with…
AbstractAims. Whether or not beta-blocker therapy should be stopped during acutely decompensated heart failure (ADHF) is unsure.Methods and results. In a random
Background—Translation of evidence-based heart failure (HF) therapies to clinical practice is incomplete and may vary internationally. We examined common measures of quality of care in…